Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication March 10, 2011
- Accepted for publication October 25, 2011
- Published online March 5, 2012.
Article Versions
- previous version (February 13, 2012 - 08:17).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2012 by the Society of Nuclear Medicine, Inc.
Author Information
- Abhinay D. Joshi1,
- Michael J. Pontecorvo1,
- Chrisopher M. Clark1,2,
- Alan P. Carpenter1,
- Danna L. Jennings3,
- Carl H. Sadowsky4,
- Lee P. Adler5,
- Karel D. Kovnat5,
- John P. Seibyl3,6,7,
- Anupa Arora1,
- Krishnendu Saha1,
- Jason D. Burns1,
- Mark J. Lowrey1,
- Mark A. Mintun1,
- Daniel M. Skovronsky1,2 and
- the Florbetapir F 18 Study Investigators
- 1Avid Radiopharmaceuticals, Inc., Philadelphia, Pennsylvania
- 2Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania
- 3Molecular NeuroImaging, LLC, New Haven, Connecticut
- 4Nova SE University, Ft. Lauderdale, Florida
- 5Adler Institute for Advanced Imaging, Jenkintown, Pennsylvania
- 6Institute for Neurodegenerative Disorders, New Haven, Connecticut; and
- 7Yale University School of Medicine, New Haven, Connecticut
- For correspondence or reprints contact: Abhinay D. Joshi, Avid Radiopharmaceuticals, 3711 Market St., 7th Floor, Philadelphia, PA 19104. E-mail: joshi{at}avidrp.com
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- Accuracy and Longitudinal Consistency of PET/MR Attenuation Correction in Amyloid PET Imaging amid Software and Hardware Upgrades
- APOE4 and Chronic Health Risk Factors are Associated with Sex-Specific Preclinical Alzheimers Disease Neuroimaging Biomarkers
- Analyzing heterogeneity in Alzheimer Disease using multimodal normative modeling on imaging-based ATN biomarkers
- Quantitative Brain Amyloid PET
- Alignments between cortical neurochemical systems, proteinopathy and neurophysiological alterations along the Alzheimers disease continuum
- Machine learning based on event-related oscillations of working memory differentiates between preclinical Alzheimers disease and neurotypical aging
- Machine learning prediction of future amyloid beta positivity in amyloid-negative individuals
- The RSNA QIBA Profile for Amyloid PET as an Imaging Biomarker for Cerebral Amyloid Quantification
- Association of CSF GAP-43 With the Rate of Cognitive Decline and Progression to Dementia in Amyloid-Positive Individuals
- Effect of cognitive reserve on physiological measures of cognitive workload in older adults with cognitive impairments
- A Pragmatic, Data-Driven Method to Determine Cutoffs for CSF Biomarkers of Alzheimer Disease Based on Validation Against PET Imaging
- Predicting Amyloid Positivity in Cognitively Unimpaired Older Adults: A Machine Learning Approach Using A4 Data
- Falls: a marker of preclinical Alzheimer disease: a cohort study protocol
- Temporal Dynamics of {beta}-Amyloid Accumulation in Aging and Alzheimer Disease
- Memory Resilience in Alzheimer Disease With Primary Progressive Aphasia
- Effect of Aerobic Exercise on Amyloid Accumulation in Preclinical Alzheimers: A 1-Year Randomized Controlled Trial
- Towards harmonizing subtyping methods for neuroimaging studies in Alzheimers disease
- Derivation and utility of an A{beta}-PET pathology accumulation index to estimate A{beta} load
- Patterns of neurodegeneration in dementia reflect a global functional state space
- Association of amyloid-{beta} CSF/PET discordance and tau load 5 years later
- Amyloid-{beta} CSF/PET discordance vs tau load 5 years later: It takes two to tangle
- APOE interacts with tau PET to influence memory independently of amyloid PET
- Time between milestone events in the Alzheimers disease amyloid cascade
- Objective subtle cognitive difficulties predict future amyloid accumulation and neurodegeneration
- Sex-specific norms for verbal memory tests may improve diagnostic accuracy of amnestic MCI
- Addition of Genetics to Quantitative MRI Facilitates Earlier Prediction of Dementia: A Non-invasive Alternative to Amyloid Measures
- Spatial relationships between white matter degeneration, amyloid load and cortical volume in amnestic mild cognitive impairment
- Impact of Reference and Target Region Selection on Amyloid PET SUV Ratios in the Phase 1b PRIME Study of Aducanumab
- Regional amyloid accumulation and cognitive decline in initially amyloid-negative adults
- Flortaucipir F 18 Quantitation Using Parametric Estimation of Reference Signal Intensity
- Test-Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18
- Spatiotemporal Distribution of {beta}-Amyloid in Alzheimer Disease Is the Result of Heterogeneous Regional Carrying Capacities
- Increased florbetapir binding in the temporal neocortex from age 20 to 60 years
- In vivo staging of regional amyloid deposition
- Amyloid deposition in younger adults is linked to episodic memory performance
- Aphasic variant of Alzheimer disease: Clinical, anatomic, and genetic features
- The ARIC-PET amyloid imaging study: Brain amyloid differences by age, race, sex, and APOE
- Relationship of regional brain {beta}-amyloid to gait speed
- A Semiautomated Method for Quantification of F 18 Florbetapir PET Images
- Optimal Target Region for Subject Classification on the Basis of Amyloid PET Images
- Use of Standardized Uptake Value Ratios Decreases Interreader Variability of [18F] Florbetapir PET Brain Scan Interpretation
- Measurement of Longitudinal {beta}-Amyloid Change with 18F-Florbetapir PET and Standardized Uptake Value Ratios
- Improved Power for Characterizing Longitudinal Amyloid-{beta} PET Changes and Evaluating Amyloid-Modifying Treatments with a Cerebral White Matter Reference Region
- Brain structure and function as mediators of the effects of amyloid on memory
- Systematic Comparison of the Performance of Integrated Whole-Body PET/MR Imaging to Conventional PET/CT for 18F-FDG Brain Imaging in Patients Examined for Suspected Dementia
- Amyloid and APOE {varepsilon}4 interact to influence short-term decline in preclinical Alzheimer disease
- PET Quantification of 18F-Florbetaben Binding to {beta}-Amyloid Deposits in Human Brains
- Amyloid-{beta} Imaging with Pittsburgh Compound B and Florbetapir: Comparing Radiotracers and Quantification Methods
- Apolipoprotein E, Not Fibrillar {beta}-Amyloid, Reduces Cerebral Glucose Metabolism in Normal Aging
- Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography